Deutsch Intern
Institute for Clinical Epidemiology and Biometry

PD Dr. Michael Schuler

Prof. Dr. phil. habil. Michael Schuler (Dipl.-Psych.)

Phone:   +49 (0)931 /31 80488
Fax: +49 (0)931 /31 840880
E-Mail: m.schuler@uni-wuerzburg.de

 

short CV

since 2019 Research Associate, Institute of Clinical Epidemiology and Biometry, University Würzburg
2006-2019    Research Associate, Abteilung Medizinische Psychologie und Psychotherapie, Medizinische Soziologie und Rehabilitationswissenschaften, University Würzburg
2019 Habilitation
2016-2019 Clinical psychologist Universitätsklinikum Würzburg
2014 Promotion Dr. phil. (summa cum laude) at the Univ. Freiburg
since 2006 Training as Psychological Psychotherapist
2006-2016 Lecturer for Psychology at the Vocational School for Speech Therapy Würzburg (Part-time)
2004-2006 Method-Consult
1996-2004 Studies of psychology at the University of Heidelberg

 

Research intrests

 

Evaluation of existing and development of new forms of care for patients with chronic diseases, psychological aspects of chronic diseases, development and psychometric testing of Patient Reported Outcome Measures

 

 

 

Main Publications in recent years

2023[ to top ]
  • 1.
    Gerlich C, Leven L, Pamperin I, Vorsatz N, Vogel H, Schuler M. Ein "Blaufeuer" für psychisch belastete Erwerbstätige - wird die Zielgruppe erreicht?. In: Deutsche Rentenversicherung, editor. 32. Rehabilitationswissenschaftliches Kolloquium. Deutscher Kongress für Rehabilitationsforschung, "Veränderungskultur fördern - Teilhabe stärken - Zukunft gestalten". Hannover: DRV-Schriften; 2023. pp. 363-5.
  • 1.
    Vogel H, Schuler M, Gerlich C, Leven L, Myrczik J, Lieb B, et al. Projekt „Systemisches Eingliederungsmanagement bei Menschen mit psychischen Beeinträchtigungen“ (SEMPsych) – die „Blaufeuer“-Intervention für Erwerbstätige mit psychischer Belastung: Zugangs-, Prozess- und Ergebnisevaluation. Gesundheitswesen [Internet]. 2023;85(08/09):[234]. Available from: http://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0043-1770543
2022[ to top ]
  • 1.
    Hayden MC, Schwarzl G, Limbach M, Mitrea S, Schuler M, Nowak D, et al. Negative association between fatigue and signs of sleep apnoea in patients after COVID-19. ERJ Open Res. 2022;8(4).
  • 1.
    Leven L, Schuler M, Gerlich C, Kemter H, Vogel H. Das Blaufeuer-Beratungsangebot für Menschen mit psychischen Beeinträchtigungen und beruflichen Belastungen. In: Stein R KHW, editor. Psychische Belastungen in der Berufsbiografie, interdisziplinäre Perspektiven. Bielefeld: WBV-Publikation; 2022. pp. 223-31. (Reihe Teilhabe an Beruf und Arbeit).
  • 1.
    Jírů-Hillmann S, Gabriel KMA, Schuler M, Wiedmann S, Mühler J, Dötter K, et al. Experiences of family caregivers 3-months after stroke: results of the prospective trans-regional network for stroke intervention with telemedicine registry (TRANSIT-Stroke). BMC Geriatrics [Internet]. 2022;22(1):228. Available from: https://doi.org/10.1186/s12877-022-02919-6
  • 1.
    Leven L, Schuler M, Gerlich C, Bilda S, Pamperin I, Vogel H. Blaufeuer - Der unabhängige Lotse bei psychischen Belastungen am Arbeitsplatz. In: Giesert M RT, editor. Mit psychischer Beeinträchtigung umgehen (anstatt sie zu umgehen). Betriebliches Eingliederungsmanagement/BEM. Hamburg: VSA-Verlag; 2022. pp. 206-15.
  • 1.
    Hayden M, Limbach M, Schuler M, Schwarzl G, Merkl S, Botosch K, et al. Patient-reported outcome measures 3 and 6 months after pulmonary rehabilitation following COVID-19. European Respiratory Journal [Internet]. 2022;60(suppl 66):1853. Available from: http://erj.ersjournals.com/content/60/suppl_66/1853.abstract
2021[ to top ]
  • 1.
    Heß V, Meng K, Schulte T, Neuderth S, Bengel J, Jentschke E, et al. Unexpressed psychosocial needs in cancer patients at the beginning of inpatient rehabilitation: a qualitative analysis. Journal of Psychosocial Oncology [Internet]. 2021;39(2):173-88. Available from: https://doi.org/10.1080/07347332.2020.1819931
  • 1.
    Schultz K, Schuler M. Sozialmedizinischer Status von COPD Patienten 12 Monate nach stationärer Rehabilitation. Pneumologie. 2021;75(S 01):S41.
  • 1.
    Schwarzl G, Hayden M, Limbach M, Merkl S, Jakab K, Botosch K, et al. Increased rates of obstructive sleep apnea (OSA) in COVID-19-patients. European Respiratory Journal. 2021;58(suppl 65):PA2081.
  • 1.
    Schwarzl G, Hayden M, Limbach M, Merkl S, Jakab K, Botosch K, et al. Obstruktive Schlafapnoe (OSA) bei Patienten in pneumologischer Rehabilitation nach COVID-19. Pneumologie. 2021;75(S 01):FV664.
  • 1.
    Limbach M, Hayden M, Nowak D, Schwarzl G, Merkl S, Schuler M, et al. Pneumologische Rehabilitation bei Post-Covid-19-Patienten: Erfahrungen und Kurzzeitbehandlungsergebnisse. Pneumologie. 2021;75(S 01):S51.
  • 1.
    Hayden MC, Limbach M, Schuler M, Merkl S, Schwarzl G, Jakab K, et al. Effectiveness of a Three-Week Inpatient Pulmonary Rehabilitation Program for Patients after COVID-19: A Prospective Observational Study. Int J Environ Res Public Health. 2021;18(17).
  • 1.
    Schultz K, Wittmann M, Wagner R, Lehbert N, Schwarzkopf L, Szentes B, et al. In-Patient Pulmonary Rehabilitation to Improve Asthma Control–A Randomized Controlled Study (EPRA, Effectiveness of Pulmonary Rehabilitation for Patients with Asthma). Dtsch Arztebl Int. 2021;118(3):23-30.
  • 1.
    Heß V, Meng K, Schulte T, Neuderth S, Bengel J, Faller H, et al. Decreased mental health, quality of life, and utilization of professional help in cancer patients with unexpressed needs: A longitudinal analysis. Psycho-Oncology [Internet]. 2021;31(5):725-34. Available from: https://doi.org/10.1002/pon.5856
  • 1.
    Geidl W, Carl J, Schuler M, Mino E, Lehbert N, Wittmann M, et al. Long-Term Benefits of Adding a Pedometer to Pulmonary Rehabilitation for COPD: The Randomized Controlled STAR Trial. Int J Chron Obstruct Pulmon Dis. 2021;16:1977-88.
  • 1.
    Böckmann D, Szentes BL, Schultz K, Nowak D, Schuler M, Schwarzkopf L. Cost-Effectiveness of Pulmonary Rehabilitation in Patients With Bronchial Asthma: An Analysis of the EPRA Randomized Controlled Trial. Value Health. 2021;24(9):1254-62.
  • 1.
    Carl JA, Geidl W, Schuler M, Mino E, Lehbert N, Wittmann M, et al. Towards a better understanding of physical activity in people with COPD: predicting physical activity after pulmonary rehabilitation using an integrative competence model. Chronic Respiratory Disease [Internet]. 2021;18:1479973121994781. Available from: https://journals.sagepub.com/doi/abs/10.1177/1479973121994781
  • 1.
    Schultz K, Schwarzkopf L, Szentes B, Nowak D, Schuler M. Reduzierte Exazerbationsraten 3 Monate und 1 Jahr nach pneumologischer Rehabilitation bei Patienten mit nicht kontrolliertem Asthma–Sekundäranalyse der EPRA-RCT. Pneumologie. 2021;75(S 01):S8-S9.
  • 1.
    Schultz K, Limbach M, Schuler M, Carl J, Pfeifer K, Geidl W. Die Zunahme der körperlichen Aktivität (physical activity) 6 Wochen nach einer stationären pneumologischen Rehabilitation bei COPD-Patienten korreliert mit einer Verbesserung der Lebensqualität. Pneumologie. 2021;75(S 01):S7.
  • 1.
    Meng K, Heß V, Schulte T, Faller H, Schuler M. Health literacy bei onkologischen Rehabilitanden und deren Relevanz für den subjektiven Rehabilitationsverlauf [The Impact of Health literacy on Health Outcomes in Cancer Patients Attending Inpatient Rehabilitation]. Die Rehabilitation. 2021;60(02):102-9.
  • 1.
    Merkl S, Limbach M, Hayden M, Schwarzl G, Nowak D, Schuler M, et al. Wirksamkeit von Inspirationsmuskeltraining in der pneumologischen Rehabilitation bei Post-Covid-19-Patienten. Pneumologie. 2021;75(S 01):P737.
  • 1.
    Hayden M, Limbach M, Schuler M, Merkl S, Schwarzl G, Jakab K, et al. Short-term Effects of a Three-week Inpatient Post-COVID-19 Pulmonary Rehabilitation Program - a Prospective Observational Study. PREPRINT (Version 1) available at Research Square [https://doi.org/10.21203/rs.3.rs-578230/v1]; 2021.
  • 1.
    Schmid B, Schulz SM, Schuler M, Göpfert D, Hein G, Heuschmann P, et al. Impaired psychological well-being of healthcare workers in a German department of anesthesiology is independent of immediate SARS-CoV-2 exposure - a longitudinal observational study. Ger Med Sci. 2021;19:Doc11.
  • 1.
    Eichner FA, Reis JM, Dores J, Pavlovic V, Kreß L, Daneshkhah N, et al. Cross-sectional study on patients’ understanding and views of the informed consent procedure of a secondary stroke prevention trial. European Journal of Neurology [Internet]. 2021;28(8):2639-47. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/ene.14917
2020[ to top ]
  • 1.
    Szentes BL, Schultz K, Nowak D, Schuler M, Schwarzkopf L. How does the EQ-5D-5L perform in asthma patients compared with an asthma-specific quality of life questionnaire?. BMC Pulmonary Medicine [Internet]. 2020;20(1):168. Available from: https://doi.org/10.1186/s12890-020-01205-8
  • 1.
    Ebert F, Schuler M, Nowak D, Schwarzkopf L, Szentes B, Schultz K. Does pulmonary rehabilitation (PR) affect dysfunctional breathing (DB) in asthmatics?. European Respiratory Journal. 2020;56(suppl 64):2939.
  • 1.
    Heß V, Meng K, Schulte T, Neuderth S, Bengel J, Faller H, et al. Prevalence and predictors of cancer patients’ unexpressed needs in the admission interview of inpatient rehabilitation. Psycho-Oncology [Internet]. 2020;29(10):1549-56. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/pon.5450
  • 1.
    Schwartz U, Llamazares M, Pohl S, Richter M, Schuler M, Keller C, et al. Combined genome-wide transcriptomic and epigenetic profiling across disease stages identifies novel regulators of COPD in human lung fibroblasts. European Respiratory Journal. 2020;56(suppl 64):2587.
  • 1.
    Zetzl T, Mann D, Gruner S, Schuler M, Jentschke E, Neuderth S, et al. Question prompts to empower cancer patients: results of a randomized controlled trial. Supportive Care in Cancer [Internet]. 2020;28(6):2571-9. Available from: https://doi.org/10.1007/s00520-019-05036-0
2019[ to top ]
  • 1.
    Reijnders T, Schuler M, Wittmann M, Jelusic D, Troosters T, Janssens W, et al. The impact of disease-specific fears on outcome measures of pulmonary rehabilitation in patients with COPD. Respiratory Medicine [Internet]. 2019;146:87-95. Available from: https://www.sciencedirect.com/science/article/pii/S0954611118303883
  • 1.
    Schultz K, Wittmann M, Lehbert N, Schwarzkopf L, Szentes B, Nowak D, et al. Asthma control (AC) and Quality of life (QoL) one year after Pulmonary Rehabilitation (PR). European Respiratory Journal. 2019;54(suppl 63):PA513.
  • 1.
    Zetzl T, Schuler M, Renner A, Jentschke E, van Oorschot B. Yoga intervention and reminder e-mails for reducing cancer-related fatigue - a study protocol of a randomized controlled trial. BMC Psychology [Internet]. 2019;7(1):64. Available from: https://doi.org/10.1186/s40359-019-0339-3
  • 1.
    Schultz K, Wittmann M, Wagner R, Lehbert N, Schwarzkopf L, Szentes B, et al. EPRA-RCT: Effektivität pneumologischer Rehabilitation bei Asthma. Vols. 73. 2019.
  • 1.
    Schuler M, Murauer K, Stangl S, Grau A, Gabriel K, Podger L, et al. Pre-post changes in main outcomes of medical rehabilitation in Germany: protocol of a systematic review and meta-analysis of individual participant and aggregated data. BMJ Open. 2019;9(5):e023826.
  • 1.
    Sindlinger K, Meng K, Dorn M, Faller H, Schuler M. Illness representations, pain and physical function in patients with rheumatic disorders: between- and within-person associations. Psychology & Health [Internet]. 2019;34(2):200-15. Available from: https://doi.org/10.1080/08870446.2018.1523406
  • 1.
    Alma H, de Jong C, Jelusic D, Wittmann M, Schuler M, Kollen B, et al. Baseline health status and setting impacted minimal clinically important differences in COPD: an exploratory study. Journal of Clinical Epidemiology [Internet]. 2019;116:49-61. Available from: https://www.sciencedirect.com/science/article/pii/S0895435618309922
  • 1.
    Bethge M, Markus M, Streibelt M, Gerlich C, Schuler M. Effects of nationwide implementation of work-related medical rehabilitation in Germany: propensity score matched analysis. Occupational and Environmental Medicine [Internet]. 2019;76(12):913. Available from: http://oem.bmj.com/content/76/12/913.abstract
  • 1.
    Achstetter LI, Schultz K, Faller H, Schuler M. Leventhal’s common-sense model and asthma control: Do illness representations predict success of an asthma rehabilitation?. Journal of Health Psychology [Internet]. 2019;24(3):327-36. Available from: https://journals.sagepub.com/doi/abs/10.1177/1359105316651332
  • 1.
    Alma HJ, de Jong C, Jelusic D, Wittmann M, Schuler M, Sanderman R, et al. Thresholds for clinically important deterioration versus improvement in COPD health status: results from a randomised controlled trial in pulmonary rehabilitation and an observational study during routine clinical practice. BMJ Open. 2019;9(6):e025776.
2018[ to top ]
  • 1.
    Schultz K, Jelusic D, Wittmann M, Krämer B, Huber V, Fuchs S, et al. Inspiratory muscle training does not improve clinical outcomes in 3-week COPD rehabilitation: results from a randomised controlled trial. European Respiratory Journal [Internet]. 2018;51(1):1702000. Available from: https://erj.ersjournals.com/content/erj/51/1/1702000.full.pdf
  • 1.
    Heß V, Schuler M, Meng K, Schulte T, Bengel J, Faller H. Psychosoziale Bedürfnisse und Belastungen bei onkologischen Rehabilitanden: Warum werden sie im Aufnahmegespräch nicht geäußert bzw. erkannt?. Psychother Psychosom Med Psychol. 2018;68(08):e44.
  • 1.
    Reijnders T, Schuler M, Jelusic D, Troosters T, Janssens W, Schultz K, et al. The Impact of Loneliness on Outcomes of Pulmonary Rehabilitation in Patients with COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease [Internet]. 2018;15(5):446-53. Available from: https://doi.org/10.1080/15412555.2018.1471128
  • 1.
    Schuler M, Strohmayer M, Mühlig S, Schwaighofer B, Wittmann M, Faller H, et al. Assessment of depression before and after inpatient rehabilitation in COPD patients: Psychometric properties of the German version of the Patient Health Questionnaire (PHQ-9/PHQ-2). Journal of Affective Disorders [Internet]. 2018;232:268-75. Available from: https://www.sciencedirect.com/science/article/pii/S0165032717324291
  • 1.
    Bethge M, Markus M, Streibelt M, Gerlich C, Schuler M. Implementing the German Model of Work-Related Medical Rehabilitation: Did the Delivered Dose of Work-Related Treatment Components Increase?. Archives of Physical Medicine and Rehabilitation [Internet]. 2018;99(12):2465-71. Available from: https://www.sciencedirect.com/science/article/pii/S0003999318304441
  • 1.
    Schuler M, Wittmann M, Faller H, Schultz K. The interrelations among aspects of dyspnea and symptoms of depression in COPD patients – a network analysis. Journal of Affective Disorders [Internet]. 2018;240:33-40. Available from: https://www.sciencedirect.com/science/article/pii/S0165032718307651
  • 1.
    Lingner H, Schmidt K, Aumann-Suslin I, Wittmann M, Schuler M, Schultz K. Reha-Komponenten im Patientenfokus – Sekundärdatenauswertung der Befragungen von COPD- und Asthma-Rehabilitanden. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen [Internet]. 2018;135-136:41-9. Available from: https://www.sciencedirect.com/science/article/pii/S1865921718300618
  • 1.
    Alma HJ, de Jong C, Jelusic D, Wittmann M, Schuler M, Kollen BJ, et al. Assessing health status over time: impact of recall period and anchor question on the minimal clinically important difference of copd health status tools. Health and Quality of Life Outcomes [Internet]. 2018;16(1):130. Available from: https://doi.org/10.1186/s12955-018-0950-7
  • 1.
    Schuler M, Wittmann M, Faller H, Schultz K. Including changes in dyspnea after inpatient rehabilitation improves prediction models of exacerbations in COPD. Respiratory Medicine [Internet]. 2018;141:87-93. Available from: https://www.sciencedirect.com/science/article/pii/S0954611118302257